DD139520A5 - Verfahren zur herstellung eines deoxynarasinkomplexes - Google Patents

Verfahren zur herstellung eines deoxynarasinkomplexes Download PDF

Info

Publication number
DD139520A5
DD139520A5 DD78208586A DD20858678A DD139520A5 DD 139520 A5 DD139520 A5 DD 139520A5 DD 78208586 A DD78208586 A DD 78208586A DD 20858678 A DD20858678 A DD 20858678A DD 139520 A5 DD139520 A5 DD 139520A5
Authority
DD
German Democratic Republic
Prior art keywords
deoxynarasine
narasin
antibiotic
epi
deoxy
Prior art date
Application number
DD78208586A
Other languages
German (de)
English (en)
Inventor
Walter M Nakatsukasa
Gary G Marconi
Norbert Neuss
Robert L Hamill
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD139520A5 publication Critical patent/DD139520A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/485—Streptomyces aureofaciens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/889—Streptomyces aureofaciens

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DD78208586A 1977-10-20 1978-10-20 Verfahren zur herstellung eines deoxynarasinkomplexes DD139520A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/844,087 US4141907A (en) 1977-10-20 1977-10-20 Deoxynarasin antibiotics

Publications (1)

Publication Number Publication Date
DD139520A5 true DD139520A5 (de) 1980-01-09

Family

ID=25291778

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78208586A DD139520A5 (de) 1977-10-20 1978-10-20 Verfahren zur herstellung eines deoxynarasinkomplexes

Country Status (33)

Country Link
US (1) US4141907A (ja)
EP (1) EP0001709B1 (ja)
JP (1) JPS5470276A (ja)
AR (1) AR217869A1 (ja)
AT (1) AT362499B (ja)
AU (1) AU519966B2 (ja)
BE (1) BE871274A (ja)
CA (1) CA1119541A (ja)
CH (1) CH636903A5 (ja)
CS (1) CS204037B2 (ja)
DD (1) DD139520A5 (ja)
DE (1) DE2861882D1 (ja)
DK (1) DK465978A (ja)
ES (1) ES474327A1 (ja)
FI (1) FI58791C (ja)
FR (1) FR2406639A1 (ja)
GB (1) GB2006774B (ja)
GR (1) GR71734B (ja)
HU (1) HU179463B (ja)
IE (1) IE47665B1 (ja)
IL (1) IL55738A (ja)
IT (1) IT1101615B (ja)
MX (1) MX5603E (ja)
MY (1) MY8500595A (ja)
NO (1) NO783545L (ja)
NZ (1) NZ188670A (ja)
PH (1) PH14339A (ja)
PL (1) PL117570B1 (ja)
PT (1) PT68661A (ja)
RO (1) RO77417A (ja)
SU (1) SU818492A3 (ja)
YU (1) YU241578A (ja)
ZA (1) ZA785804B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2024806B (en) * 1978-03-16 1982-05-06 Taisho Pharmaceutical Co Ltd Onomycin derivatives
IE49936B1 (en) * 1979-07-11 1986-01-08 Int Minerals & Chem Corp Zinc-containing antibiotic agents
US4309504A (en) * 1980-01-28 1982-01-05 Eli Lilly And Company Process for preparing narasin
US4394377A (en) * 1981-07-31 1983-07-19 Syntex (U.S.A.) Inc. Ruminant animal performance by co-administering choline and propionate enchancers
US4625041A (en) * 1984-02-17 1986-11-25 Pfizer Inc. Acidic polycyclic ether antibiotic
US4859599A (en) * 1984-10-11 1989-08-22 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
US4613503A (en) * 1984-10-11 1986-09-23 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
US5041374A (en) * 1986-05-29 1991-08-20 International Minerals & Chemical Corp. Polyether antibiotic recovery and purification
US5049495A (en) * 1986-05-29 1991-09-17 International Minerals & Chemical Corp. Fermentation method for producing polyether antibiotics
US5047338A (en) * 1986-05-29 1991-09-10 International Minerals & Chemical Corp. Polyester Antibiotic preparation
WO2008033466A2 (en) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases
CN108743905A (zh) * 2018-08-24 2018-11-06 河南科技大学第附属医院 一种治疗感冒的中药配方及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753887A (en) 1969-06-04 1973-08-21 Hydronautics Alkali metal specific measuring electrode
US3947586A (en) 1974-05-20 1976-03-30 Hoffmann-La Roche Inc. Method of combatting swine dysentery
US4038384A (en) * 1974-06-10 1977-07-26 Eli Lilly And Company Antibiotic a-28086 and process for production thereof
US3985893A (en) 1974-10-29 1976-10-12 Eli Lilly And Company Method for treating cardiac insufficiency with antibiotic A-23187
US4035481A (en) 1975-04-21 1977-07-12 Eli Lilly And Company Antibiotic A-28086 and process for production thereof
US4009262A (en) 1975-04-21 1977-02-22 Eli Lilly And Company Antibiotic a-28086 recovery process

Also Published As

Publication number Publication date
IT7828926A0 (it) 1978-10-19
EP0001709A3 (en) 1979-05-16
JPS6244553B2 (ja) 1987-09-21
AU519966B2 (en) 1982-01-07
FI58791C (fi) 1981-04-10
IL55738A0 (en) 1978-12-17
CH636903A5 (fr) 1983-06-30
CS204037B2 (en) 1981-03-31
AT362499B (de) 1981-05-25
BE871274A (fr) 1979-04-17
FI783174A (fi) 1979-04-21
PT68661A (en) 1978-11-01
MY8500595A (en) 1985-12-31
FR2406639A1 (fr) 1979-05-18
SU818492A3 (ru) 1981-03-30
GB2006774A (en) 1979-05-10
IE47665B1 (en) 1984-05-16
IL55738A (en) 1981-10-30
EP0001709B1 (en) 1982-06-02
RO77417A (ro) 1981-11-04
PL117570B1 (en) 1981-08-31
CA1119541A (en) 1982-03-09
HU179463B (en) 1982-10-28
MX5603E (es) 1983-11-07
DK465978A (da) 1979-06-15
NO783545L (no) 1979-04-23
FR2406639B1 (ja) 1981-08-14
EP0001709A2 (en) 1979-05-02
YU241578A (en) 1982-10-31
ZA785804B (en) 1980-05-28
PL210410A1 (pl) 1979-10-22
ES474327A1 (es) 1979-11-01
US4141907A (en) 1979-02-27
AU4077678A (en) 1980-04-24
NZ188670A (en) 1981-05-29
IE782078L (en) 1979-04-20
PH14339A (en) 1981-05-29
DE2861882D1 (en) 1982-07-22
ATA750778A (de) 1980-10-15
IT1101615B (it) 1985-10-07
FI58791B (fi) 1980-12-31
GR71734B (ja) 1983-06-22
GB2006774B (en) 1982-09-02
JPS5470276A (en) 1979-06-05
AR217869A1 (es) 1980-04-30

Similar Documents

Publication Publication Date Title
EP0035119B1 (de) Polyätherverbindungen und ihre Herstellung, entsprechende Präparate und die Verwendung dieser Produkte als Heilmittel oder wachstumsfördernde Mittel bei Wiederkäuern
DD139520A5 (de) Verfahren zur herstellung eines deoxynarasinkomplexes
DD210072A5 (de) Verfahren zur herstellung des antibiotikums a47934
US4174404A (en) Deoxynarasin antibiotics
US4510317A (en) Antibiotic X-14934A
US4591559A (en) Antibiotic X-14934A and a method for its preparation
DE3003624A1 (de) Antibiotica c-19393 s tief 2 und h tief 2
CH634853A5 (de) Schwefelhaltige metabolite, ihre herstellung und verwendung in arznei- und futtermitteln.
DE2404958C2 (de) Metabolit A-27106 und Verfahren zu seiner Herstellung
EP0236894B1 (de) Efomycin G, seine Herstellung und seine Verwendung als Leistungsförderer bei Tieren
US4204039A (en) Process for producing deoxynarasin antibiotics
DE2209018C2 (de) Glycopeptid-Antibioticum-A-4696-Hydrochlorid und dieses enthaltendes Tierfuttermittel
EP0183214A2 (de) Organisch-chemische Verbindung, mikrobiologische Verfahren zu ihrer Herstellung sowie ihre Verwendung
US4582853A (en) Treatment of coccidiosis with antibiotic X-14934A
DE2652677A1 (de) Antibiotica 890a tief 1 und 890a tief 3
DE3511753A1 (de) Verwendung von efomycinen als wachstumsfoerderer, efomycine und ihre herstellung
DE2262501A1 (de) Neue antibiotica, ihre herstellung und ihre verwendung in wiederkaeuerfutter
DE2900688A1 (de) Deoxynarasin-antibiotika, verfahren zu ihrer herstellung und ihre verwendung
AT349878B (de) Futtermittel
DE2703938C2 (de) Antibiotikamischung A-7413, Antibiotikum A-7413 Faktoren A, B, C und D und Verwendung der Antibiotikamischung oder ihrer isolierten Faktoren A, B, C und D als wachstumsförderndes Mittel bei Geflügel
DE2525095C2 (de) Polyetherantibiotika A-28086 A, B und D, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Futtermittel
DE2608337A1 (de) Neue organische verbindung, ihre herstellung und verwendung
DE2534342A1 (de) Als verbindung 38 295 bezeichnetes antibiotikum, verfahren zu seiner herstellung und seine verwendung
DE2944143C2 (de) Antibiotikum SF-2052, Verfahren zu dessen Herstellung und das Antibiotikum SF-2052 enthaltende antibakterielle Mittel
CH579147A5 (en) Antiparasitic streptomyces hygroscopicus metabolite - i.e. septamycine, as antibacterials, antiprotozoals, anthelminthics and coccidiostats